nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCB1—melanoma	0.189	1	CbGaD
Mifepristone—ABCC1—Vemurafenib—melanoma	0.185	0.294	CbGbCtD
Mifepristone—ABCC1—Dactinomycin—melanoma	0.123	0.195	CbGbCtD
Mifepristone—ABCC1—Docetaxel—melanoma	0.0635	0.101	CbGbCtD
Mifepristone—CYP3A4—Temozolomide—melanoma	0.0488	0.0775	CbGbCtD
Mifepristone—CYP2D6—Vemurafenib—melanoma	0.0421	0.0668	CbGbCtD
Mifepristone—CYP3A7—Docetaxel—melanoma	0.0314	0.0498	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0314	0.0498	CbGbCtD
Mifepristone—ABCB1—Dactinomycin—melanoma	0.0297	0.0471	CbGbCtD
Mifepristone—CYP3A4—Vemurafenib—melanoma	0.0268	0.0425	CbGbCtD
Mifepristone—CYP3A5—Docetaxel—melanoma	0.0235	0.0374	CbGbCtD
Mifepristone—ABCB1—Docetaxel—melanoma	0.0153	0.0243	CbGbCtD
Mifepristone—CYP3A4—Docetaxel—melanoma	0.00918	0.0146	CbGbCtD
Mifepristone—Erythema nodosum—Vemurafenib—melanoma	0.00461	0.0445	CcSEcCtD
Mifepristone—Rash maculo-papular—Vemurafenib—melanoma	0.00181	0.0175	CcSEcCtD
Mifepristone—Pain in extremity—Vemurafenib—melanoma	0.00145	0.014	CcSEcCtD
Mifepristone—Vaginal haemorrhage—Temozolomide—melanoma	0.00138	0.0133	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.0013	0.0126	CcSEcCtD
Mifepristone—Infestation NOS—Vemurafenib—melanoma	0.00112	0.0108	CcSEcCtD
Mifepristone—Infestation—Vemurafenib—melanoma	0.00112	0.0108	CcSEcCtD
Mifepristone—Oedema peripheral—Vemurafenib—melanoma	0.000987	0.00953	CcSEcCtD
Mifepristone—Connective tissue disorder—Vemurafenib—melanoma	0.000984	0.00951	CcSEcCtD
Mifepristone—Angiopathy—Vemurafenib—melanoma	0.000909	0.00878	CcSEcCtD
Mifepristone—Mediastinal disorder—Vemurafenib—melanoma	0.000903	0.00872	CcSEcCtD
Mifepristone—Chills—Vemurafenib—melanoma	0.000899	0.00868	CcSEcCtD
Mifepristone—Malnutrition—Vemurafenib—melanoma	0.000872	0.00842	CcSEcCtD
Mifepristone—Back pain—Vemurafenib—melanoma	0.000843	0.00815	CcSEcCtD
Mifepristone—Hot flush—Temozolomide—melanoma	0.000791	0.00764	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Temozolomide—melanoma	0.000784	0.00757	CcSEcCtD
Mifepristone—Menopausal symptoms—Temozolomide—melanoma	0.000784	0.00757	CcSEcCtD
Mifepristone—Thirst—Temozolomide—melanoma	0.000778	0.00751	CcSEcCtD
Mifepristone—Myalgia—Vemurafenib—melanoma	0.000742	0.00717	CcSEcCtD
Mifepristone—Arthralgia—Vemurafenib—melanoma	0.000742	0.00717	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000737	0.00712	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000737	0.00712	CcSEcCtD
Mifepristone—Infection—Vemurafenib—melanoma	0.000707	0.00683	CcSEcCtD
Mifepristone—Nervous system disorder—Vemurafenib—melanoma	0.000698	0.00674	CcSEcCtD
Mifepristone—Hypokalaemia—Carmustine—melanoma	0.000697	0.00673	CcSEcCtD
Mifepristone—Skin disorder—Vemurafenib—melanoma	0.000691	0.00668	CcSEcCtD
Mifepristone—Muscular weakness—Carmustine—melanoma	0.000675	0.00652	CcSEcCtD
Mifepristone—Hypokalaemia—Temozolomide—melanoma	0.000673	0.0065	CcSEcCtD
Mifepristone—Breast disorder—Temozolomide—melanoma	0.000669	0.00646	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000666	0.00644	CcSEcCtD
Mifepristone—Hypotension—Vemurafenib—melanoma	0.000665	0.00642	CcSEcCtD
Mifepristone—Muscular weakness—Temozolomide—melanoma	0.000653	0.0063	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000648	0.00626	CcSEcCtD
Mifepristone—Decreased appetite—Vemurafenib—melanoma	0.000619	0.00597	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Vemurafenib—melanoma	0.000614	0.00593	CcSEcCtD
Mifepristone—Fatigue—Vemurafenib—melanoma	0.000614	0.00593	CcSEcCtD
Mifepristone—Haemoglobin—Bleomycin—melanoma	0.00061	0.00589	CcSEcCtD
Mifepristone—Constipation—Vemurafenib—melanoma	0.000609	0.00588	CcSEcCtD
Mifepristone—Haemorrhage—Bleomycin—melanoma	0.000607	0.00586	CcSEcCtD
Mifepristone—Infestation NOS—Temozolomide—melanoma	0.00057	0.00551	CcSEcCtD
Mifepristone—Infestation—Temozolomide—melanoma	0.00057	0.00551	CcSEcCtD
Mifepristone—Body temperature increased—Vemurafenib—melanoma	0.000563	0.00543	CcSEcCtD
Mifepristone—Chills—Bleomycin—melanoma	0.000545	0.00526	CcSEcCtD
Mifepristone—Sinusitis—Temozolomide—melanoma	0.000535	0.00517	CcSEcCtD
Mifepristone—Haemoglobin—Carmustine—melanoma	0.000532	0.00514	CcSEcCtD
Mifepristone—Haemorrhage—Carmustine—melanoma	0.00053	0.00512	CcSEcCtD
Mifepristone—Hot flush—Docetaxel—melanoma	0.000526	0.00508	CcSEcCtD
Mifepristone—Hypersensitivity—Vemurafenib—melanoma	0.000524	0.00506	CcSEcCtD
Mifepristone—Oedema peripheral—Carmustine—melanoma	0.000522	0.00504	CcSEcCtD
Mifepristone—Menopausal symptoms—Docetaxel—melanoma	0.000522	0.00504	CcSEcCtD
Mifepristone—Connective tissue disorder—Carmustine—melanoma	0.000521	0.00503	CcSEcCtD
Mifepristone—Haemoglobin—Temozolomide—melanoma	0.000515	0.00497	CcSEcCtD
Mifepristone—Haemorrhage—Temozolomide—melanoma	0.000512	0.00494	CcSEcCtD
Mifepristone—Asthenia—Vemurafenib—melanoma	0.000511	0.00493	CcSEcCtD
Mifepristone—Chills—Dactinomycin—melanoma	0.000508	0.0049	CcSEcCtD
Mifepristone—Oedema peripheral—Temozolomide—melanoma	0.000504	0.00487	CcSEcCtD
Mifepristone—Pruritus—Vemurafenib—melanoma	0.000503	0.00486	CcSEcCtD
Mifepristone—Connective tissue disorder—Temozolomide—melanoma	0.000503	0.00486	CcSEcCtD
Mifepristone—Pain in extremity—Docetaxel—melanoma	0.000492	0.00475	CcSEcCtD
Mifepristone—Ill-defined disorder—Bleomycin—melanoma	0.00049	0.00473	CcSEcCtD
Mifepristone—Diarrhoea—Vemurafenib—melanoma	0.000487	0.0047	CcSEcCtD
Mifepristone—Malaise—Bleomycin—melanoma	0.000476	0.0046	CcSEcCtD
Mifepristone—Dizziness—Vemurafenib—melanoma	0.000471	0.00454	CcSEcCtD
Mifepristone—Angiopathy—Temozolomide—melanoma	0.000464	0.00449	CcSEcCtD
Mifepristone—Mental disorder—Carmustine—melanoma	0.000464	0.00448	CcSEcCtD
Mifepristone—Mediastinal disorder—Temozolomide—melanoma	0.000461	0.00446	CcSEcCtD
Mifepristone—Malnutrition—Carmustine—melanoma	0.000461	0.00445	CcSEcCtD
Mifepristone—Chills—Temozolomide—melanoma	0.000459	0.00444	CcSEcCtD
Mifepristone—Ill-defined disorder—Dactinomycin—melanoma	0.000457	0.00442	CcSEcCtD
Mifepristone—Vomiting—Vemurafenib—melanoma	0.000452	0.00437	CcSEcCtD
Mifepristone—Myalgia—Bleomycin—melanoma	0.00045	0.00434	CcSEcCtD
Mifepristone—Rash—Vemurafenib—melanoma	0.000449	0.00433	CcSEcCtD
Mifepristone—Mental disorder—Temozolomide—melanoma	0.000449	0.00433	CcSEcCtD
Mifepristone—Dermatitis—Vemurafenib—melanoma	0.000448	0.00433	CcSEcCtD
Mifepristone—Back pain—Carmustine—melanoma	0.000446	0.00431	CcSEcCtD
Mifepristone—Headache—Vemurafenib—melanoma	0.000446	0.00431	CcSEcCtD
Mifepristone—Malnutrition—Temozolomide—melanoma	0.000446	0.0043	CcSEcCtD
Mifepristone—Breast disorder—Docetaxel—melanoma	0.000445	0.00429	CcSEcCtD
Mifepristone—Discomfort—Bleomycin—melanoma	0.000444	0.00429	CcSEcCtD
Mifepristone—Malaise—Dactinomycin—melanoma	0.000444	0.00429	CcSEcCtD
Mifepristone—Cramp muscle—Docetaxel—melanoma	0.000443	0.00428	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000443	0.00428	CcSEcCtD
Mifepristone—Nasopharyngitis—Docetaxel—melanoma	0.00044	0.00425	CcSEcCtD
Mifepristone—Oedema—Bleomycin—melanoma	0.000431	0.00416	CcSEcCtD
Mifepristone—Back pain—Temozolomide—melanoma	0.000431	0.00416	CcSEcCtD
Mifepristone—Infection—Bleomycin—melanoma	0.000428	0.00414	CcSEcCtD
Mifepristone—Nausea—Vemurafenib—melanoma	0.000423	0.00408	CcSEcCtD
Mifepristone—Myalgia—Dactinomycin—melanoma	0.000419	0.00405	CcSEcCtD
Mifepristone—Discomfort—Dactinomycin—melanoma	0.000414	0.004	CcSEcCtD
Mifepristone—Ill-defined disorder—Temozolomide—melanoma	0.000413	0.00399	CcSEcCtD
Mifepristone—Anorexia—Bleomycin—melanoma	0.000411	0.00397	CcSEcCtD
Mifepristone—Angioedema—Temozolomide—melanoma	0.000407	0.00393	CcSEcCtD
Mifepristone—Hypotension—Bleomycin—melanoma	0.000403	0.00389	CcSEcCtD
Mifepristone—Oedema—Dactinomycin—melanoma	0.000402	0.00388	CcSEcCtD
Mifepristone—Malaise—Temozolomide—melanoma	0.000402	0.00388	CcSEcCtD
Mifepristone—Infection—Dactinomycin—melanoma	0.000399	0.00386	CcSEcCtD
Mifepristone—Hypertension—Carmustine—melanoma	0.000398	0.00385	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000393	0.00379	CcSEcCtD
Mifepristone—Myalgia—Carmustine—melanoma	0.000393	0.00379	CcSEcCtD
Mifepristone—Anxiety—Carmustine—melanoma	0.000391	0.00378	CcSEcCtD
Mifepristone—Hypertension—Temozolomide—melanoma	0.000385	0.00372	CcSEcCtD
Mifepristone—Dyspnoea—Bleomycin—melanoma	0.000384	0.00371	CcSEcCtD
Mifepristone—Anorexia—Dactinomycin—melanoma	0.000383	0.0037	CcSEcCtD
Mifepristone—Arthralgia—Temozolomide—melanoma	0.000379	0.00366	CcSEcCtD
Mifepristone—Myalgia—Temozolomide—melanoma	0.000379	0.00366	CcSEcCtD
Mifepristone—Infestation NOS—Docetaxel—melanoma	0.000379	0.00366	CcSEcCtD
Mifepristone—Infestation—Docetaxel—melanoma	0.000379	0.00366	CcSEcCtD
Mifepristone—Anxiety—Temozolomide—melanoma	0.000378	0.00365	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000377	0.00364	CcSEcCtD
Mifepristone—Oedema—Carmustine—melanoma	0.000376	0.00363	CcSEcCtD
Mifepristone—Discomfort—Temozolomide—melanoma	0.000375	0.00362	CcSEcCtD
Mifepristone—Decreased appetite—Bleomycin—melanoma	0.000375	0.00362	CcSEcCtD
Mifepristone—Infection—Carmustine—melanoma	0.000374	0.00361	CcSEcCtD
Mifepristone—Dry mouth—Temozolomide—melanoma	0.000371	0.00358	CcSEcCtD
Mifepristone—Pain—Bleomycin—melanoma	0.000369	0.00356	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000366	0.00354	CcSEcCtD
Mifepristone—Oedema—Temozolomide—melanoma	0.000364	0.00351	CcSEcCtD
Mifepristone—Infection—Temozolomide—melanoma	0.000361	0.00349	CcSEcCtD
Mifepristone—Anorexia—Carmustine—melanoma	0.000359	0.00346	CcSEcCtD
Mifepristone—Nervous system disorder—Temozolomide—melanoma	0.000357	0.00344	CcSEcCtD
Mifepristone—Feeling abnormal—Bleomycin—melanoma	0.000355	0.00343	CcSEcCtD
Mifepristone—Skin disorder—Temozolomide—melanoma	0.000353	0.00341	CcSEcCtD
Mifepristone—Hypotension—Carmustine—melanoma	0.000352	0.0034	CcSEcCtD
Mifepristone—Decreased appetite—Dactinomycin—melanoma	0.00035	0.00338	CcSEcCtD
Mifepristone—Fatigue—Dactinomycin—melanoma	0.000347	0.00335	CcSEcCtD
Mifepristone—Anorexia—Temozolomide—melanoma	0.000347	0.00335	CcSEcCtD
Mifepristone—Pain—Dactinomycin—melanoma	0.000344	0.00332	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Carmustine—melanoma	0.000343	0.00331	CcSEcCtD
Mifepristone—Urticaria—Bleomycin—melanoma	0.000343	0.00331	CcSEcCtD
Mifepristone—Haemoglobin—Docetaxel—melanoma	0.000342	0.0033	CcSEcCtD
Mifepristone—Body temperature increased—Bleomycin—melanoma	0.000341	0.00329	CcSEcCtD
Mifepristone—Haemorrhage—Docetaxel—melanoma	0.00034	0.00329	CcSEcCtD
Mifepristone—Insomnia—Carmustine—melanoma	0.00034	0.00329	CcSEcCtD
Mifepristone—Dyspnoea—Carmustine—melanoma	0.000336	0.00324	CcSEcCtD
Mifepristone—Oedema peripheral—Docetaxel—melanoma	0.000335	0.00324	CcSEcCtD
Mifepristone—Somnolence—Carmustine—melanoma	0.000335	0.00323	CcSEcCtD
Mifepristone—Connective tissue disorder—Docetaxel—melanoma	0.000335	0.00323	CcSEcCtD
Mifepristone—Feeling abnormal—Dactinomycin—melanoma	0.000331	0.0032	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000331	0.0032	CcSEcCtD
Mifepristone—Insomnia—Temozolomide—melanoma	0.000329	0.00318	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dactinomycin—melanoma	0.000329	0.00318	CcSEcCtD
Mifepristone—Decreased appetite—Carmustine—melanoma	0.000327	0.00316	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Carmustine—melanoma	0.000325	0.00314	CcSEcCtD
Mifepristone—Dyspnoea—Temozolomide—melanoma	0.000324	0.00313	CcSEcCtD
Mifepristone—Somnolence—Temozolomide—melanoma	0.000323	0.00312	CcSEcCtD
Mifepristone—Pain—Carmustine—melanoma	0.000322	0.00311	CcSEcCtD
Mifepristone—Constipation—Carmustine—melanoma	0.000322	0.00311	CcSEcCtD
Mifepristone—Abdominal pain—Dactinomycin—melanoma	0.000318	0.00307	CcSEcCtD
Mifepristone—Body temperature increased—Dactinomycin—melanoma	0.000318	0.00307	CcSEcCtD
Mifepristone—Hypersensitivity—Bleomycin—melanoma	0.000318	0.00307	CcSEcCtD
Mifepristone—Decreased appetite—Temozolomide—melanoma	0.000316	0.00305	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Temozolomide—melanoma	0.000314	0.00303	CcSEcCtD
Mifepristone—Fatigue—Temozolomide—melanoma	0.000314	0.00303	CcSEcCtD
Mifepristone—Pain—Temozolomide—melanoma	0.000311	0.003	CcSEcCtD
Mifepristone—Constipation—Temozolomide—melanoma	0.000311	0.003	CcSEcCtD
Mifepristone—Feeling abnormal—Carmustine—melanoma	0.00031	0.003	CcSEcCtD
Mifepristone—Asthenia—Bleomycin—melanoma	0.000309	0.00299	CcSEcCtD
Mifepristone—Angiopathy—Docetaxel—melanoma	0.000309	0.00298	CcSEcCtD
Mifepristone—Gastrointestinal pain—Carmustine—melanoma	0.000308	0.00297	CcSEcCtD
Mifepristone—Mediastinal disorder—Docetaxel—melanoma	0.000307	0.00296	CcSEcCtD
Mifepristone—Chills—Docetaxel—melanoma	0.000305	0.00295	CcSEcCtD
Mifepristone—Pruritus—Bleomycin—melanoma	0.000305	0.00295	CcSEcCtD
Mifepristone—Feeling abnormal—Temozolomide—melanoma	0.0003	0.00289	CcSEcCtD
Mifepristone—Mental disorder—Docetaxel—melanoma	0.000298	0.00288	CcSEcCtD
Mifepristone—Body temperature increased—Carmustine—melanoma	0.000298	0.00287	CcSEcCtD
Mifepristone—Abdominal pain—Carmustine—melanoma	0.000298	0.00287	CcSEcCtD
Mifepristone—Gastrointestinal pain—Temozolomide—melanoma	0.000297	0.00287	CcSEcCtD
Mifepristone—Malnutrition—Docetaxel—melanoma	0.000296	0.00286	CcSEcCtD
Mifepristone—Hypersensitivity—Dactinomycin—melanoma	0.000296	0.00286	CcSEcCtD
Mifepristone—Urticaria—Temozolomide—melanoma	0.000289	0.00279	CcSEcCtD
Mifepristone—Asthenia—Dactinomycin—melanoma	0.000289	0.00279	CcSEcCtD
Mifepristone—Body temperature increased—Temozolomide—melanoma	0.000288	0.00278	CcSEcCtD
Mifepristone—Abdominal pain—Temozolomide—melanoma	0.000288	0.00278	CcSEcCtD
Mifepristone—Back pain—Docetaxel—melanoma	0.000287	0.00277	CcSEcCtD
Mifepristone—Muscle spasms—Docetaxel—melanoma	0.000285	0.00275	CcSEcCtD
Mifepristone—Hypersensitivity—Carmustine—melanoma	0.000277	0.00268	CcSEcCtD
Mifepristone—Diarrhoea—Dactinomycin—melanoma	0.000275	0.00266	CcSEcCtD
Mifepristone—Vomiting—Bleomycin—melanoma	0.000274	0.00265	CcSEcCtD
Mifepristone—Rash—Bleomycin—melanoma	0.000272	0.00263	CcSEcCtD
Mifepristone—Dermatitis—Bleomycin—melanoma	0.000272	0.00262	CcSEcCtD
Mifepristone—Asthenia—Carmustine—melanoma	0.00027	0.00261	CcSEcCtD
Mifepristone—Hypersensitivity—Temozolomide—melanoma	0.000268	0.00259	CcSEcCtD
Mifepristone—Asthenia—Temozolomide—melanoma	0.000261	0.00252	CcSEcCtD
Mifepristone—Diarrhoea—Carmustine—melanoma	0.000258	0.00249	CcSEcCtD
Mifepristone—Pruritus—Temozolomide—melanoma	0.000257	0.00249	CcSEcCtD
Mifepristone—Nausea—Bleomycin—melanoma	0.000256	0.00247	CcSEcCtD
Mifepristone—Hypertension—Docetaxel—melanoma	0.000256	0.00247	CcSEcCtD
Mifepristone—Vomiting—Dactinomycin—melanoma	0.000256	0.00247	CcSEcCtD
Mifepristone—Rash—Dactinomycin—melanoma	0.000254	0.00245	CcSEcCtD
Mifepristone—Arthralgia—Docetaxel—melanoma	0.000252	0.00244	CcSEcCtD
Mifepristone—Myalgia—Docetaxel—melanoma	0.000252	0.00244	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000251	0.00242	CcSEcCtD
Mifepristone—Dizziness—Carmustine—melanoma	0.000249	0.0024	CcSEcCtD
Mifepristone—Diarrhoea—Temozolomide—melanoma	0.000249	0.0024	CcSEcCtD
Mifepristone—Dry mouth—Docetaxel—melanoma	0.000247	0.00238	CcSEcCtD
Mifepristone—Oedema—Docetaxel—melanoma	0.000242	0.00234	CcSEcCtD
Mifepristone—Dizziness—Temozolomide—melanoma	0.000241	0.00232	CcSEcCtD
Mifepristone—Infection—Docetaxel—melanoma	0.00024	0.00232	CcSEcCtD
Mifepristone—Vomiting—Carmustine—melanoma	0.000239	0.00231	CcSEcCtD
Mifepristone—Nausea—Dactinomycin—melanoma	0.000239	0.00231	CcSEcCtD
Mifepristone—Rash—Carmustine—melanoma	0.000237	0.00229	CcSEcCtD
Mifepristone—Nervous system disorder—Docetaxel—melanoma	0.000237	0.00229	CcSEcCtD
Mifepristone—Dermatitis—Carmustine—melanoma	0.000237	0.00229	CcSEcCtD
Mifepristone—Headache—Carmustine—melanoma	0.000236	0.00228	CcSEcCtD
Mifepristone—Skin disorder—Docetaxel—melanoma	0.000235	0.00227	CcSEcCtD
Mifepristone—Vomiting—Temozolomide—melanoma	0.000231	0.00223	CcSEcCtD
Mifepristone—Anorexia—Docetaxel—melanoma	0.000231	0.00223	CcSEcCtD
Mifepristone—Rash—Temozolomide—melanoma	0.000229	0.00221	CcSEcCtD
Mifepristone—Dermatitis—Temozolomide—melanoma	0.000229	0.00221	CcSEcCtD
Mifepristone—Headache—Temozolomide—melanoma	0.000228	0.0022	CcSEcCtD
Mifepristone—Hypotension—Docetaxel—melanoma	0.000226	0.00218	CcSEcCtD
Mifepristone—Nausea—Carmustine—melanoma	0.000224	0.00216	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Docetaxel—melanoma	0.00022	0.00213	CcSEcCtD
Mifepristone—Insomnia—Docetaxel—melanoma	0.000219	0.00211	CcSEcCtD
Mifepristone—Nausea—Temozolomide—melanoma	0.000216	0.00209	CcSEcCtD
Mifepristone—Dyspnoea—Docetaxel—melanoma	0.000216	0.00208	CcSEcCtD
Mifepristone—Somnolence—Docetaxel—melanoma	0.000215	0.00208	CcSEcCtD
Mifepristone—Decreased appetite—Docetaxel—melanoma	0.00021	0.00203	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Docetaxel—melanoma	0.000209	0.00202	CcSEcCtD
Mifepristone—Fatigue—Docetaxel—melanoma	0.000209	0.00201	CcSEcCtD
Mifepristone—Pain—Docetaxel—melanoma	0.000207	0.002	CcSEcCtD
Mifepristone—Constipation—Docetaxel—melanoma	0.000207	0.002	CcSEcCtD
Mifepristone—Feeling abnormal—Docetaxel—melanoma	0.000199	0.00192	CcSEcCtD
Mifepristone—Gastrointestinal pain—Docetaxel—melanoma	0.000198	0.00191	CcSEcCtD
Mifepristone—Abdominal pain—Docetaxel—melanoma	0.000191	0.00185	CcSEcCtD
Mifepristone—Body temperature increased—Docetaxel—melanoma	0.000191	0.00185	CcSEcCtD
Mifepristone—Hypersensitivity—Docetaxel—melanoma	0.000178	0.00172	CcSEcCtD
Mifepristone—Asthenia—Docetaxel—melanoma	0.000174	0.00168	CcSEcCtD
Mifepristone—Pruritus—Docetaxel—melanoma	0.000171	0.00165	CcSEcCtD
Mifepristone—Diarrhoea—Docetaxel—melanoma	0.000165	0.0016	CcSEcCtD
Mifepristone—Dizziness—Docetaxel—melanoma	0.00016	0.00154	CcSEcCtD
Mifepristone—Vomiting—Docetaxel—melanoma	0.000154	0.00149	CcSEcCtD
Mifepristone—Rash—Docetaxel—melanoma	0.000153	0.00147	CcSEcCtD
Mifepristone—Dermatitis—Docetaxel—melanoma	0.000152	0.00147	CcSEcCtD
Mifepristone—Headache—Docetaxel—melanoma	0.000152	0.00146	CcSEcCtD
Mifepristone—Nausea—Docetaxel—melanoma	0.000144	0.00139	CcSEcCtD
Mifepristone—CYP3A7—Metabolism—FASN—melanoma	1.6e-05	0.000206	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HPSE—melanoma	1.6e-05	0.000205	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SPP1—melanoma	1.59e-05	0.000204	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAP2K2—melanoma	1.59e-05	0.000204	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGF1—melanoma	1.58e-05	0.000203	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—SLC5A5—melanoma	1.58e-05	0.000202	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CUBN—melanoma	1.57e-05	0.000201	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—VDR—melanoma	1.57e-05	0.000201	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PHGDH—melanoma	1.54e-05	0.000197	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—LUM—melanoma	1.54e-05	0.000197	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PDGFRA—melanoma	1.53e-05	0.000196	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NOTCH1—melanoma	1.53e-05	0.000196	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GNAQ—melanoma	1.52e-05	0.000195	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CD44—melanoma	1.52e-05	0.000195	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.52e-05	0.000195	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SDHD—melanoma	1.52e-05	0.000194	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—BSG—melanoma	1.52e-05	0.000194	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CSPG4—melanoma	1.52e-05	0.000194	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PRKCA—melanoma	1.51e-05	0.000194	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TERT—melanoma	1.51e-05	0.000194	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HPSE—melanoma	1.51e-05	0.000193	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RAC1—melanoma	1.51e-05	0.000193	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERCC2—melanoma	1.5e-05	0.000193	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—VCAN—melanoma	1.49e-05	0.000191	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAP2K2—melanoma	1.48e-05	0.00019	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CUBN—melanoma	1.48e-05	0.00019	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.48e-05	0.00019	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GPAM—melanoma	1.47e-05	0.000188	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP1B1—melanoma	1.46e-05	0.000187	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HIF1A—melanoma	1.44e-05	0.000185	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PRKCA—melanoma	1.44e-05	0.000185	CbGpPWpGaD
Mifepristone—AR—Gene Expression—PPARG—melanoma	1.44e-05	0.000185	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.44e-05	0.000184	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ERCC2—melanoma	1.43e-05	0.000184	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—BSG—melanoma	1.43e-05	0.000183	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CSPG4—melanoma	1.43e-05	0.000183	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SDHD—melanoma	1.43e-05	0.000183	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TERT—melanoma	1.41e-05	0.000181	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HLA-A—melanoma	1.41e-05	0.000181	CbGpPWpGaD
Mifepristone—ABCC1—Disease—RAC1—melanoma	1.4e-05	0.00018	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.4e-05	0.000179	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GPAM—melanoma	1.38e-05	0.000177	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KDR—melanoma	1.38e-05	0.000177	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ABCB1—melanoma	1.38e-05	0.000177	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.37e-05	0.000176	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.37e-05	0.000176	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HIF1A—melanoma	1.35e-05	0.000173	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FN1—melanoma	1.33e-05	0.000171	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.3e-05	0.000167	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH1—melanoma	1.3e-05	0.000167	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—melanoma	1.29e-05	0.000166	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.29e-05	0.000166	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CD80—melanoma	1.28e-05	0.000164	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APC—melanoma	1.27e-05	0.000163	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KIT—melanoma	1.27e-05	0.000163	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CG—melanoma	1.27e-05	0.000163	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PRKCA—melanoma	1.27e-05	0.000163	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGF—melanoma	1.26e-05	0.000161	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ERCC2—melanoma	1.26e-05	0.000161	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP17A1—melanoma	1.25e-05	0.000161	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PLA2G6—melanoma	1.25e-05	0.00016	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PLCB4—melanoma	1.23e-05	0.000158	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS2—melanoma	1.23e-05	0.000157	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOTCH1—melanoma	1.21e-05	0.000156	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ABCB1—melanoma	1.2e-05	0.000154	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—BRAF—melanoma	1.2e-05	0.000153	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD80—melanoma	1.19e-05	0.000152	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.19e-05	0.000152	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APC—melanoma	1.19e-05	0.000152	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KIT—melanoma	1.19e-05	0.000152	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GNA11—melanoma	1.18e-05	0.000152	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PLA2G6—melanoma	1.18e-05	0.000151	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGF—melanoma	1.17e-05	0.00015	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IGF1—melanoma	1.17e-05	0.00015	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIP4K2A—melanoma	1.16e-05	0.000149	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC6A11—melanoma	1.16e-05	0.000149	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—FASN—melanoma	1.16e-05	0.000149	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH1—melanoma	1.16e-05	0.000148	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.15e-05	0.000147	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—SLC5A5—melanoma	1.14e-05	0.000146	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTAP—melanoma	1.13e-05	0.000145	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAP2K1—melanoma	1.13e-05	0.000145	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—VCAN—melanoma	1.12e-05	0.000144	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CD—melanoma	1.12e-05	0.000144	CbGpPWpGaD
Mifepristone—ABCC1—Disease—BRAF—melanoma	1.12e-05	0.000143	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MAPK3—melanoma	1.11e-05	0.000142	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PRKCA—melanoma	1.11e-05	0.000142	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GNAQ—melanoma	1.1e-05	0.000141	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CD44—melanoma	1.1e-05	0.000141	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ERCC2—melanoma	1.1e-05	0.000141	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PPARG—melanoma	1.09e-05	0.00014	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—melanoma	1.08e-05	0.000138	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGF2—melanoma	1.07e-05	0.000137	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—VCAN—melanoma	1.06e-05	0.000136	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP1B1—melanoma	1.06e-05	0.000135	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAP2K1—melanoma	1.05e-05	0.000135	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CD—melanoma	1.04e-05	0.000134	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.04e-05	0.000134	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—LUM—melanoma	1e-05	0.000129	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PHGDH—melanoma	1e-05	0.000129	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MDM2—melanoma	1e-05	0.000129	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGF2—melanoma	9.99e-06	0.000128	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CG—melanoma	9.94e-06	0.000127	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB2—melanoma	9.88e-06	0.000127	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HPSE—melanoma	9.85e-06	0.000126	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CB—melanoma	9.75e-06	0.000125	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	9.7e-06	0.000124	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CUBN—melanoma	9.67e-06	0.000124	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PPARG—melanoma	9.59e-06	0.000123	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP17A1—melanoma	9.46e-06	0.000121	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CXCL8—melanoma	9.37e-06	0.00012	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MDM2—melanoma	9.34e-06	0.00012	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—BSG—melanoma	9.34e-06	0.00012	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CSPG4—melanoma	9.34e-06	0.00012	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SDHD—melanoma	9.34e-06	0.00012	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERBB2—melanoma	9.21e-06	0.000118	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1B—melanoma	9.15e-06	0.000117	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CB—melanoma	9.09e-06	0.000117	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD4—melanoma	9.07e-06	0.000116	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GPAM—melanoma	9.05e-06	0.000116	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—melanoma	9.01e-06	0.000116	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CASP3—melanoma	8.97e-06	0.000115	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—melanoma	8.96e-06	0.000115	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GNA11—melanoma	8.93e-06	0.000115	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP17A1—melanoma	8.92e-06	0.000114	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	8.76e-06	0.000112	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—FASN—melanoma	8.74e-06	0.000112	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CD—melanoma	8.73e-06	0.000112	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—melanoma	8.73e-06	0.000112	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ABCB1—melanoma	8.69e-06	0.000111	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CG—melanoma	8.67e-06	0.000111	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CTNNB1—melanoma	8.65e-06	0.000111	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ALB—melanoma	8.62e-06	0.000111	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC5A5—melanoma	8.6e-06	0.00011	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1B—melanoma	8.53e-06	0.000109	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MMP9—melanoma	8.48e-06	0.000109	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1A—melanoma	8.45e-06	0.000108	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MAPK3—melanoma	8.44e-06	0.000108	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—melanoma	8.43e-06	0.000108	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GNA11—melanoma	8.42e-06	0.000108	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NFKB1—melanoma	8.39e-06	0.000108	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PPARG—melanoma	8.36e-06	0.000107	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GNAQ—melanoma	8.31e-06	0.000107	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CD44—melanoma	8.31e-06	0.000107	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—FASN—melanoma	8.24e-06	0.000106	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—melanoma	8.21e-06	0.000105	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC5A5—melanoma	8.1e-06	0.000104	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CTNNB1—melanoma	8.06e-06	0.000103	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PRKCA—melanoma	8e-06	0.000103	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP1B1—melanoma	7.96e-06	0.000102	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ERCC2—melanoma	7.93e-06	0.000102	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1A—melanoma	7.87e-06	0.000101	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—melanoma	7.86e-06	0.000101	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GNAQ—melanoma	7.83e-06	0.0001	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CD44—melanoma	7.83e-06	0.0001	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PLA2G6—melanoma	7.69e-06	9.87e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CD—melanoma	7.62e-06	9.77e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CB—melanoma	7.61e-06	9.77e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—melanoma	7.61e-06	9.77e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—melanoma	7.54e-06	9.68e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—melanoma	7.54e-06	9.67e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALB—melanoma	7.52e-06	9.65e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NRAS—melanoma	7.52e-06	9.65e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP1B1—melanoma	7.5e-06	9.63e-05	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—melanoma	7.47e-06	9.58e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK3—melanoma	7.2e-06	9.24e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—melanoma	7.03e-06	9.01e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NRAS—melanoma	7.01e-06	8.99e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—melanoma	7e-06	8.99e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—VCAN—melanoma	6.91e-06	8.86e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK1—melanoma	6.85e-06	8.79e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—melanoma	6.85e-06	8.79e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK3—melanoma	6.71e-06	8.61e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CB—melanoma	6.64e-06	8.52e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—melanoma	6.58e-06	8.44e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—melanoma	6.58e-06	8.44e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—melanoma	6.53e-06	8.38e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—melanoma	6.47e-06	8.3e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MAPK3—melanoma	6.4e-06	8.21e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK1—melanoma	6.39e-06	8.19e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—melanoma	6.39e-06	8.19e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CG—melanoma	6.26e-06	8.04e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—melanoma	6.23e-06	7.99e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCB1—melanoma	6.18e-06	7.93e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PPARG—melanoma	6.05e-06	7.76e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PRKCA—melanoma	6.03e-06	7.74e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—melanoma	6.03e-06	7.74e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ERCC2—melanoma	5.99e-06	7.68e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—melanoma	5.95e-06	7.63e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP17A1—melanoma	5.83e-06	7.48e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—melanoma	5.75e-06	7.38e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—melanoma	5.74e-06	7.36e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—melanoma	5.69e-06	7.3e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PRKCA—melanoma	5.69e-06	7.3e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ERCC2—melanoma	5.64e-06	7.24e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—melanoma	5.54e-06	7.11e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CD—melanoma	5.51e-06	7.07e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GNA11—melanoma	5.5e-06	7.06e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—melanoma	5.5e-06	7.06e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALB—melanoma	5.44e-06	6.97e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—FASN—melanoma	5.39e-06	6.91e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC5A5—melanoma	5.3e-06	6.8e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—melanoma	5.26e-06	6.75e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—melanoma	5.13e-06	6.58e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GNAQ—melanoma	5.12e-06	6.57e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CD44—melanoma	5.12e-06	6.57e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—melanoma	4.91e-06	6.3e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP1B1—melanoma	4.91e-06	6.29e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—melanoma	4.86e-06	6.23e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CB—melanoma	4.8e-06	6.16e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—melanoma	4.76e-06	6.1e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CG—melanoma	4.73e-06	6.06e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—melanoma	4.64e-06	5.95e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PPARG—melanoma	4.56e-06	5.85e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—melanoma	4.53e-06	5.81e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CG—melanoma	4.45e-06	5.71e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—melanoma	4.32e-06	5.54e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PPARG—melanoma	4.3e-06	5.52e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CD—melanoma	4.16e-06	5.33e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—melanoma	4.15e-06	5.32e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALB—melanoma	4.1e-06	5.26e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—melanoma	4.05e-06	5.19e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCB1—melanoma	4.04e-06	5.18e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CD—melanoma	3.92e-06	5.02e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALB—melanoma	3.87e-06	4.96e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—melanoma	3.79e-06	4.86e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PRKCA—melanoma	3.72e-06	4.77e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ERCC2—melanoma	3.69e-06	4.73e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CB—melanoma	3.62e-06	4.65e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—melanoma	3.59e-06	4.6e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CB—melanoma	3.41e-06	4.38e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—melanoma	3.38e-06	4.34e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—melanoma	3.31e-06	4.24e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—melanoma	3.13e-06	4.02e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—melanoma	2.95e-06	3.78e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—melanoma	2.93e-06	3.75e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CG—melanoma	2.91e-06	3.74e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PPARG—melanoma	2.81e-06	3.61e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CD—melanoma	2.56e-06	3.28e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALB—melanoma	2.53e-06	3.24e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—melanoma	2.39e-06	3.07e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CB—melanoma	2.23e-06	2.86e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—melanoma	2.21e-06	2.84e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—melanoma	2.21e-06	2.83e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—melanoma	2.08e-06	2.67e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—melanoma	1.93e-06	2.47e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—melanoma	1.8e-06	2.31e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—melanoma	1.7e-06	2.18e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—melanoma	1.36e-06	1.75e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—melanoma	1.11e-06	1.43e-05	CbGpPWpGaD
